UnitedHealth Group (UNH) received an upgrade from Raymond James, boosting investor confidence ahead of its first-quarter earnings report scheduled for April 21, 2026. The financial services firm upgraded UNH from a "Market Perform" rating to "Outperform," setting a price target of $330. This suggests Raymond James believes the stock has the potential to perform better than the average stock in its coverage universe.
The upgrade reflects increasing optimism regarding UnitedHealth's ability to improve its profitability through enhanced operational efficiency. Raymond James analyst John Ransom believes that Wall Street may be underestimating the company's earnings potential. According to Ransom's analysis, even a slight improvement of 100 basis points in general and administrative costs could translate to roughly $3.80 per share.
UnitedHealth is expected to report an EPS of $6.69 for Q1 2026, an 8% year-over-year decrease. Revenue is projected to be $109.58 billion. Investors will be watching closely if UnitedHealth Group can meet or exceed the new $330 price target set by Raymond James. The company's performance is closely monitored by investors and analysts as one of the largest healthcare companies in the U. S.
Additionally, positive news regarding Medicare Advantage rates for 2027 further fueled investor enthusiasm, sending UnitedHealth shares soaring. The Centers for Medicare and Medicaid Services announced a 2.48% rate increase for private insurers in 2027, exceeding initial expectations. This positive adjustment, combined with the Raymond James upgrade, has created strong tailwinds for UnitedHealth as it approaches its Q1 earnings release.
